Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | Chief Medical Officer | Common Stock | 6.73K | $49.1K | $7.29 | May 1, 2024 | Direct |
Aprea Therapeutics, Inc. | Chief Medical Officer | Stock Options (Right to Purchase) | 26.9K | May 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APRE | Aprea Therapeutics, Inc. | May 1, 2024 | 2 | $0 | 4 | May 2, 2024 | Chief Medical Officer |
APRE | Aprea Therapeutics, Inc. | May 1, 2024 | 0 | $0 | 3 | May 2, 2024 | Chief Medical Officer |